H.C. Wainwright lifts Cocrystal Pharma Inc [COCP] price estimate. Who else is bullish?

Caleb Clifford

Cocrystal Pharma Inc [NASDAQ: COCP] stock went on an upward path that rose over 9.72% on Friday, amounting to a one-week price increase of more than 7.12%.

Over the last 12 months, COCP stock dropped by -21.78%. The one-year Cocrystal Pharma Inc stock forecast points to a potential upside of 80.25. The average equity rating for COCP stock is currently 1.00, trading closer to a bullish pattern in the stock market.

The market cap for the stock reached $16.21 million, with 10.17 million shares outstanding and 7.01 million shares in the current float. Compared to the average trading volume of 75.62K shares, COCP stock reached a trading volume of 82757463 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Guru’s Opinion on Cocrystal Pharma Inc [COCP]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for COCP shares is $8.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on COCP stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

H.C. Wainwright have made an estimate for Cocrystal Pharma Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on July 08, 2020.

The Price to Book ratio for the last quarter was 3.01, with the Price to Cash per share for the same quarter was set at 0.47.

COCP Stock Performance Analysis:

Cocrystal Pharma Inc [COCP] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 7.12. With this latest performance, COCP shares dropped by -5.95% in over the last four-week period, additionally sinking by -5.39% over the last 6 months – not to mention a drop of -21.78% in the past year of trading.

Cocrystal Pharma Inc (COCP) Capital Structure & Debt Analysis

According to recent financial data for Cocrystal Pharma Inc. ( COCP), the Return on Equity (ROE) stands at -110.56%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -83.52%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Cocrystal Pharma Inc’s Return on Invested Capital (ROIC) is -188.21%, showcasing its effectiveness in deploying capital for earnings.

Cocrystal Pharma Inc (COCP) Efficiency & Liquidity Metrics

Based on Cocrystal Pharma Inc’s (COCP) latest financial statements, the Debt-to-Equity Ratio is 0.31%, indicating its reliance on debt financing relative to shareholder equity.

Cocrystal Pharma Inc (COCP) Efficiency & Liquidity Metrics

From an operational efficiency perspective, Cocrystal Pharma Inc. (COCP) effectively leverages its workforce, generating an average of -$1141818.18 per employee. The company’s liquidity position is robust, with a Current Ratio of 3.69% and a Quick Ratio of 3.69%, indicating strong ability to cover short-term liabilities.

COCP Stock EPS

With the latest financial reports released by the company, Cocrystal Pharma Inc posted -0.49/share EPS, while the average EPS was predicted by analysts to be reported at -0.57/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.08. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for COCP.

Cocrystal Pharma Inc [COCP] Institutonal Ownership Details

There are presently around $6.69%, or 10.46%% of COCP stock, in the hands of institutional investors. The top three institutional holders of COCP stocks are: VANGUARD GROUP INC with ownership of 0.28 million shares, which is approximately 2.7094%. RENAISSANCE TECHNOLOGIES LLC, holding 0.13 million shares of the stock with an approximate value of $$0.3 million in COCP stocks shares; and RENAISSANCE TECHNOLOGIES LLC, currently with $$0.17 million in COCP stock with ownership which is approximately 0.7248%.

Leave a Comment

DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.